Poncina, N., Albiero, M., Menegazzo, L., Cappellari, R., Avogaro, A., & Fadini, G. P. (2014). The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients. BioMed Central.
Chicago ZitierstilPoncina, Nicol, Mattia Albiero, Lisa Menegazzo, Roberta Cappellari, Angelo Avogaro, und Gian Paolo Fadini. The Dipeptidyl Peptidase-4 Inhibitor Saxagliptin Improves Function of Circulating Pro-angiogenic Cells From Type 2 Diabetic Patients. BioMed Central, 2014.
MLA ZitierstilPoncina, Nicol, et al. The Dipeptidyl Peptidase-4 Inhibitor Saxagliptin Improves Function of Circulating Pro-angiogenic Cells From Type 2 Diabetic Patients. BioMed Central, 2014.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.